A-29.01, r. 4 - Regulation respecting the basic prescription drug insurance plan

Full text
2. In addition to the pharmaceutical services referred to in the first paragraph of section 8 of the Act respecting prescription drug insurance (chapter A-29.01), the other pharmaceutical services whose cost is borne by Board in accordance with section 22 of that Act are the following:
(1)  refusal to fill or renew a prescription;
(2)  a pharmaceutical opinion, that is, the reasoned opinion of a pharmacist on the pharmacological and therapeutic history of an eligible person drawn up under the authority of that pharmacist or on the therapeutic value of one or a combination of treatments prescribed, given in writing to the prescriber;
(3)  transmission of a medication profile;
(4)  on-call service.
The service referred to in subparagraph (1) of the first paragraph must relate to a medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance.
The services referred to in subparagraphs (2) and (4) of the first paragraph must relate to at least one medication on the list of medications established by the Minister under section 60 of the Act respecting prescription drug insurance.
O.C. 1519-96, s. 2; O.C. 506-2015, s. 2.
2. In addition to the cost of the services rendered to fill or renew a prescription, the following pharmaceutical services are covered under the basic prescription drug insurance plan for which the Régie de l’assurance maladie du Québec provides coverage, in accordance with section 22 of the Act respecting prescription drug insurance (chapter A-29.01):
(1)  refusal to fill or renew a prescription;
(2)  a pharmaceutical opinion, that is, the reasoned opinion of a pharmacist on the pharmacological and therapeutic history of an eligible person drawn up under the authority of that pharmacist or on the therapeutic value of one or a combination of treatments prescribed, given in writing to the prescriber.
O.C. 1519-96, s. 2.